Table 4.
The top 10 co-cited references in CRF research.
| Rank | Author | Cited reference | Co-citation (%) | Centrality | Journal | IF (2021) |
|---|---|---|---|---|---|---|
| 1 | Mustian KM (9) | Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue: A Meta-analysis | 133 (1.26%) | 0.16 | JAMA Oncology | 28.37 |
| 2 | Berger AM (10) | Cancer-Related Fatigue, Version 2.2015 | 103 (0.98%) | 0.01 | Journal of the National Comprehensive Cancer Network | 13.44 |
| 3 | Bower JE (4) | Cancer-related fatigue–mechanisms, risk factors, and treatments | 99 (0.94%) | 0 | Nature Reviews Clinical Oncology | 78.77 |
| 4 | Campbell KL (11) | Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable | 62 (0.59%) | 0.01 | Medicine & Science in Sports & Exercise | 4.15 |
| 5 | Hilfiker R (12) | Exercise and other non-pharmaceutical interventions for cancer-related fatigue in patients during or after cancer treatment: a systematic review incorporating an indirect-comparisons meta-analysis | 61 (0.58%) | 0.05 | British Journal of Sports Medicine | 18.42 |
| 6 | Bower JE (13) | Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical oncology clinical practice guideline adaptation | 61 (0.58%) | 0.06 | Journal of Clinical Oncology | 45.27 |
| 7 | Abrahams HJG (14) | Risk factors, prevalence, and course of severe fatigue after breast cancer treatment: a meta-analysis involving 12 327 breast cancer survivors | 54 (0.51%) | 0.09 | Annals of Oncology | 50.45 |
| 8 | Fabi A (15) | Cancer-related fatigue: ESMO Clinical Practice Guidelines for diagnosis and treatment | 53 (0.50%) | 0.01 | Annals of Oncology | 50.45 |
| 9 | Hofman M (16) | Cancer-related fatigue: the scale of the problem | 53 (0.50%) | 0 | Oncologist | 5.76 |
| 10 | Saligan LN (17) | The biology of cancer-related fatigue: a review of the literature | 52 (0.49%) | 0.04 | Supportive Care in Cancer | 3.13 |